CAS 2167246-24-2

Formula: C18H24F2N6O

InChI: InChI=1S/C18H24F2N6O/c1-13-4-7-26(24-13)17-22-15(21-14-2-5-18(19,20)6-3-14)12-16(23-17)25-8-10-27-11-9-25/h4,7,12,14H,2-3,5-6,8-11H2,1H3,(H,21,22,23)

InChI key: OVLIDRAJVMUEMC-UHFFFAOYSA-N

SMILES: CC1=NN(C=C1)C2=NC(=CC(=N2)N3CCOCC3)NC4CCC(CC4)(F)F

Rimtuzalcap

CAS: 2167246-24-2

Rimtuzalcap

Formula: C₁₈H₂₄F₂N₆O

Purity: ≥98%

Molecular weight: 378.42

Ref: 54-BUP07975

N-(4,4-Difluorocyclohexyl)-2-(3-methyl-1H-pyrazol-1-yl)-6-morpholinopyrimidin-4-amine

CAS: 2167246-24-2

Formula: C₁₈H₂₄F₂N₆O

Molecular weight: 378.4196

Ref: IN-DA023OG5

Rimtuzalcap

CAS: 2167246-24-2

N-(4,4-Difluorocyclohexyl)-2-(3-methyl-1H-pyrazol-1-yl)-6-morpholinopyrimidin-4-amine

Formula: C₁₈H₂₄F₂N₆O

Purity: 95%

Molecular weight: 378.42

Ref: IN-DG01449724

Rimtuzalcap

CAS: 2167246-24-2

Rimtuzalcap (CAD-1883), a selective modulator for SK channels, may treat movement disorders like SCA and ET.

Formula: C₁₈H₂₄F₂N₆O

Purity: 99.64%

Color and Shape: Solid

Molecular weight: 378.4196

Ref: TM-T9522

Rimtuzalcap

CAS: 2167246-24-2

Rimtuzalcap is a monoclonal antibody, which is derived from a hybridoma technology involving the fusion of specific immune cells. It operates through the highly specific binding to a targeted antigen, thereby modulating immune responses or interfering with signaling pathways. This precision in action enhances its efficacy and minimizes off-target effects compared to broader immunomodulatory agents.

Formula: C₁₈H₂₄F₂N₆O

Purity: Min. 95%

Molecular weight: 378.42 g/mol

Ref: 3D-BR184195